1. Home
  2. CAPR vs ALNT Comparison

CAPR vs ALNT Comparison

Compare CAPR & ALNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAPR
  • ALNT
  • Stock Information
  • Founded
  • CAPR 2005
  • ALNT 1962
  • Country
  • CAPR United States
  • ALNT United States
  • Employees
  • CAPR N/A
  • ALNT N/A
  • Industry
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • ALNT Electrical Products
  • Sector
  • CAPR Health Care
  • ALNT Industrials
  • Exchange
  • CAPR Nasdaq
  • ALNT Nasdaq
  • Market Cap
  • CAPR 322.7M
  • ALNT 359.1M
  • IPO Year
  • CAPR N/A
  • ALNT N/A
  • Fundamental
  • Price
  • CAPR $8.43
  • ALNT $40.23
  • Analyst Decision
  • CAPR Strong Buy
  • ALNT Strong Buy
  • Analyst Count
  • CAPR 8
  • ALNT 3
  • Target Price
  • CAPR $24.75
  • ALNT $31.00
  • AVG Volume (30 Days)
  • CAPR 2.7M
  • ALNT 154.7K
  • Earning Date
  • CAPR 08-06-2025
  • ALNT 08-06-2025
  • Dividend Yield
  • CAPR N/A
  • ALNT 0.30%
  • EPS Growth
  • CAPR N/A
  • ALNT N/A
  • EPS
  • CAPR N/A
  • ALNT 0.58
  • Revenue
  • CAPR $17,363,588.00
  • ALNT $516,058,000.00
  • Revenue This Year
  • CAPR $453.92
  • ALNT $2.69
  • Revenue Next Year
  • CAPR N/A
  • ALNT $4.05
  • P/E Ratio
  • CAPR N/A
  • ALNT $68.60
  • Revenue Growth
  • CAPR N/A
  • ALNT N/A
  • 52 Week Low
  • CAPR $3.52
  • ALNT $16.91
  • 52 Week High
  • CAPR $23.40
  • ALNT $40.39
  • Technical
  • Relative Strength Index (RSI)
  • CAPR 38.63
  • ALNT 64.70
  • Support Level
  • CAPR $6.26
  • ALNT $38.80
  • Resistance Level
  • CAPR $7.28
  • ALNT $40.31
  • Average True Range (ATR)
  • CAPR 0.69
  • ALNT 1.10
  • MACD
  • CAPR -0.04
  • ALNT -0.19
  • Stochastic Oscillator
  • CAPR 10.28
  • ALNT 80.56

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About ALNT Allient Inc.

Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.

Share on Social Networks: